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Omega-3 fatty acids (u-3 FAs), DHA and EPA, exert
anti-inflammatory effects, but the mechanisms are
poorly understood. Here, we show that the G
protein-coupled receptor 120 (GPR120) functions as
an u-3 FA receptor/sensor. Stimulation of GPR120
with u-3 FAs or a chemical agonist causes broad
anti-inflammatory effects in monocytic RAW 264.7
cells and in primary intraperitoneal macrophages.
All of these effects are abrogated by GPR120 knock-
down. Since chronic macrophage-mediated tissue
inflammation is a key mechanism for insulin resis-
tance in obesity, we fed obese WT and GPR120
knockout mice a high-fat diet with or without u-3 FA
supplementation. The u-3 FA treatment inhibited
inflammation and enhanced systemic insulin sensi-
tivity in WT mice, but was without effect in GPR120
knockoutmice. In conclusion, GPR120 is a functional
u-3 FA receptor/sensor and mediates potent insulin
sensitizing and antidiabetic effects in vivo by repres-
sing macrophage-induced tissue inflammation.INTRODUCTION
Chronic activation of inflammatory pathways plays an important
role in the pathogenesis of insulin resistance and the macro-
phage/adipocyte nexus provides a key mechanism underlying
the common disease states of decreased insulin sensitivity
(Schenk et al., 2008). This involves migration of monocytes/
macrophages to adipose tissue (including intramuscular fat
depots) and liver with subsequent activation of macrophage
proinflammatory pathways and cytokine secretion. Through
paracrine effects, these events promote inflammation and
decreased insulin sensitivity in nearby insulin target cells
(Shoelson et al., 2007; Schenk et al., 2008). In these studies,
we explore the interlocking biology between proinflammatoryand anti-inflammatory molecules within the specialized popula-
tion of proinflammatory tissue macrophages.
G protein-coupled receptors (GPCRs) are important signaling
molecules for many aspects of cellular function. They are
members of a large family that share common structural motifs
such as seven transmembrane helices and the ability to acti-
vate heterotrimeric G proteins, such as Gas, Gai, and Gaq.
Ligands bind specifically to GPCRs to stimulate and induce
a variety of cellular responses via several second messenger
pathways; e.g., modulation of cAMP production, the phospho-
lipase C pathway, ion channels, and mitogen-activated protein
kinases (Ulloa-Aguirre et al., 1999; Gether, 2000; Schulte and
Fredholm, 2003. Recently, several groups reported that five
orphan receptors, GPR40, GPR41, GPR43, GPR84, and
GPR120, can be activated by free fatty acids (FFAs). Short-
chain fatty acids (FAs) are specific agonists for GPR41 and
GPR43 (Tazoe et al., 2008) and medium-chain FAs for GPR84
(Wang et al., 2006a). Long-chain FAs can activate GPR40
(Itoh et al., 2003) and GPR120 (Hirasawa et al., 2005). Hirasawa
et al. showed that the stimulation of GPR120 by FFAs resulted
in elevation of [Ca2+]i and activation of the ERK cascade which
suggests interactions with the Gaq family of G proteins.
However, other physiological functions of GPR120 remain to
be explored. In the current study, we found that GPR120 was
highly expressed in adipose tissue, and proinflammatory
macrophages. The high expression level of GPR120 in mature
adipocytes and macrophages indicates that GPR120 might
play an important role in these cell types. We stimulated
GPR120 with a synthetic agonist (GW9508) and omega-3 fatty
acids (u-3 FAs) and examined whether activation of GPR120
affected LPS- and TNF-a-induced inflammatory signaling
responses. While SFAs are proinflammatory and unsaturated
FAs are generally neutral, we found that u-3 FAs (docosahex-
aenoic acid (C22:6n3, DHA) and eicosapentaenoic acid
(C20:5n3, EPA)), the major ingredients in fish oil, exert potent
anti-inflammatory effects through GPR120.
b-arrestins can serve as scaffold or adaptor proteins for a wide
range of GPCRs, as well as a selected group of other receptor
subtypes (Miller and Lefkowitz, 2001). After ligand binding,
b-arrestins can associate with the cytoplasmic domains ofCell 142, 687–698, September 3, 2010 ª2010 Elsevier Inc. 687
Figure 1. Expression Level of GPR120 and
GPR120-Mediated Anti-inflammatory Res-
ponse in RAW 264.7 Cells
(A and B) (A) The mRNA expression pattern of
various lipid sensing GPCRs is shown in adipose
tissue, (B) CD11c+ bone marrow-derived dendritic
cells (BMDCs), bone marrow-derived macro-
phages (BMDMs), IPMacs, 3T3-L1 preadipocytes,
differentiated 3T3-L1 adipocytes, RAW 264.7
cells, and L6 myocytes. Ribosomal protein S3
(RPS3) was used as internal control.
(C) Expression of GPR120 in SVF, adipocytes and
hepatic Kupffer cells from chow (NC)- or HFD-fed
mice was examined by q-PCR. Data are ex-
pressed as the mean ± SEM of at least three
independent experiments in triplicate. *p < 0.05
versus NC.
(D) RAW 264.7 cells, transfected with scrambled
(Scr) or GPR120 #2 siRNA (GPR120 KD), were
treated with 100 mM of GW9508 for 1 hr prior to
LPS (100 ng/ml) treatment for 10 min and then
subjected to western blotting. Left panel is a repre-
sentative image from three independent experi-
ments, and the scanned bar graph (right panel)
shows fold induction over basal conditions.
Knockdown efficiency of GPR120 siRNA is shown
in Figure S1.
(E) Cytokine secretion level was measured in RAW
264.7 cells by ELISA. Data are expressed as the
mean ± SEM of three independent experiments.
*p < 0.05 versus LPS treatment in scrambled
siRNA transfected cells. See also Figures S1
and S2.GPCRs and couple the receptor to specific downstream
signaling pathways, as well as mediate receptor endocytosis
(Luttrell and Lefkowitz, 2002). Here we find that b-arrestin2 asso-
ciates with ligand-stimulated GPR120 and participates in down-
stream signaling mechanisms.
Since chronic inflammation is a mechanistic feature of
obesity-related insulin resistance, we postulated that the anti-
inflammatory effect of GPR120 stimulation could promote insulin
sensitization. In the present study, we elucidate the role of
GPR120 activation in integrating anti-inflammatory and insulin
sensitizing effects in vitro and in vivo.
RESULTS
GPR120 Expression
Fatty acids (FAs) can function as endogenous ligands modu-
lating inflammatory responses, but not all FAs work in the
sameway. In general, saturated FAs (SFAs) are proinflammatory,
unsaturated FAs are weakly proinflammatory or neutral, and u3-
FAs can be anti-inflammatory (Lee et al., 2003; Calder, 2005;
Solinas et al., 2007). Because of the importance of inflammation
in a number of chronic human diseases including insulin resis-
tance, obesity, and type 2 diabetes mellitus, we surveyed the
family of FA sensing GPCRs (GPR40, 41, 43, 84, and 120). Based
on its tissue expression pattern, GPR120 emerged as a receptor
of particular interest. As seen in Figure 1, GPR120 is the only lipid688 Cell 142, 687–698, September 3, 2010 ª2010 Elsevier Inc.sensing GPCR which is highly expressed in adipose tissue,
proinflammatory CD11c+macrophages (BMDCs), mature adipo-
cytes, and monocytic RAW 264.7 cells (Figure 1A and 1B).
GPR120 is induced in the stromal vascular fraction (SVF) of
adipose tissue (which contains the macrophages), as well as in
hepatic Kupffer cells, during high-fat diet (HFD) feeding in mice
(Figure 1C). GPR120 is also expressed in enteroendocrine L cells
with negligible expression in muscle (Figure S4C available
online), hepatocytes or other cell types (Hirasawa et al., 2005;
Gotoh et al., 2007).
Ligand-Stimulated GPR120 Exerts Anti-inflammatory
Effects
It has been previously reported that GPR120 signals via
a Gaq/11-coupled pathway and can respond to long chain FAs
(Hirasawa et al., 2005). To pursue the biology of GPR120,
a tool compound was needed, and, some years ago, Glaxo pub-
lished GW9508 as a GPR40 selective agonist. However, this
compound was not specific and also stimulated GPR120 (Bris-
coe et al., 2006). Since macrophages and adipocytes do not
express GPR40 (this was confirmed by repeated q-PCR and
RT-PCR measures, Figure S1A), GW9508 is a functional
GPR120 specific compound in these cell types. Using this
approach, we found that GW9508 treatment broadly and mark-
edly repressed the ability of the TLR4 ligand LPS to stimulate
inflammatory responses in RAW 264.7 cells (Figure 1D and E).
Figure 2. Omega-3 FA Stimulates GPR120
and Mediates Anti-inflammatory Effects
(A–D) GPR120-mediated SRE-luc activity after
treatment with various FAs. Results are fold
activities over basal. Each data point represents
mean ± SEM of three independent experiments
performed in triplicate. Black lines indicate SRE-
luc activities without GPR120 transfection or with
non-stimulating FAs. DHA inhibits LPS-induced
inflammatory signaling (B), cytokine secretion (C),
and inflammatory gene mRNA expression level
(D) in RAW 264.7 cells, but not in GPR120 knock-
down cells.
(E and F) GPR120 stimulation inhibits LPS-induced
inflammatory response in WT primary macro-
phage. Data are expressed as the mean ± SEM
of three independent experiments. *p < 0.05
versus LPS treatment in scrambled siRNA trans-
fected cells or WT IPMacs. See also Figure S2.Thus, GW9508 inhibited LPS stimulated phosphorylation of IKKb
and JNK, prevented IkB degradation, and inhibited TNF-a and
IL-6 secretion. All of these effects of GW9508 were completely
abrogated by siRNA mediated knockdown of GPR120 (Figures
1D and 1E and Figure S1F).
Based on these remarkable anti-inflammatory effects of
GPR120 stimulation, we established a cell based reporter
system by transfecting HEK293 cells with constructs for
GPR120 along with a serum response element-luciferase
promoter/reporter (SRE-luc). Since GPR120 is a Gaq/11-
coupled receptor, it stimulates both PKC and MAP kinase, and
both of these biologic effects are detected by the SRE-driven
reporter system (Oh et al., 2005). The reporter cells were treated
with various FAs and the synthetic GW9508 ligand. We found
that GW9508, the u-3 FAs (DHA and EPA) and palmitoleate
(C16:1n7), all activated the SRE-luc reporter with an EC50 of
1-10 mM (Figure 2A), while SFAs were without effect. GW9508
and DHA were used at 100 mM in all subsequent studies to
achieve maximal action. The u-3 FAs (DHA and a-linolenic
acid), and SFA (palmitic acid (C16:0)) activated ERK phosphory-Cell 142, 687–698, Slation in RAW 264.7 cells, but only DHA-
and a-linolenic acid-mediated ERK phos-
phorylation were abolished by GPR120
knockdown (Figure S2A). These results
indicate that u-3 FAs, but not SFAs,
specifically activated ERK via GPR120.
The activation of GPR120 by u-3 FAs,
as well as its expression in adipocytes
and macrophages, led us to study
whether DHA, a representative u-3 FA,
can modulate inflammation through
GPR120 in these cells. To examine this,
we pretreated RAW 264.7 cells and
3T3-L1 adipocytes with GW9508 or DHA
for 1 hr, followed by LPS (TLR4), TNF-a,
TLR2, or TLR3 stimulation, respectively.
We found that GW9508 and, more impor-
tantly, DHA, strongly inhibited LPS-induced phosphorylation of JNK and IKKb, IkB degradation,
cytokine secretion and inflammatory gene expression level in
RAW 264.7 cells (Figures 2B–2D) as well as TNF-a, TLR2 and
TLR3-induced JNK and IKKb phosphorylation in 3T3-L1 adipo-
cytes (Figure S2B) or RAW 264.7 cells (Figure S2C). All of the
effects of GW9508 and DHA were completely prevented by
GPR120 knockdown, demonstrating that these anti-inflamma-
tory effects were specifically exerted through GPR120 (Figure 1,
Figure 2, Figure S1, and Figure S2). Similar results were seen in
primary wild-type (WT) intraperitoneal macrophages (IPMacs)
and GPR120 knockout (KO) IPMacs (Figures 2E and 2F). These
data argue that GPR120 is an u-3 FA receptor or sensor, and
provide amolecular mechanism for the anti-inflammatory effects
of this class of FAs.
Role of b-arrestin2 in GPR120 Signaling
Given these potent cell selective anti-inflammatory effects,
it was of interest to understand the specific mechanisms
whereby signals from GPR120 inhibit inflammatory pathways.
To further assess this, we used RNA interference to examineeptember 3, 2010 ª2010 Elsevier Inc. 689
Figure 3. GPR120 Internalization with
b-arrestin2 Mediates Anti-inflammatory
Effects
(A) RAW264.7 cellswere transfectedwith siRNAas
indicated and stimulated with or without 100 mMof
DHA 1 hr prior to LPS (100 ng/ml) treatment for
10 min and then subjected to western blotting.
(B) TNF-a secretion was measured in RAW 264.7
cell cultured media with or without RNA interfer-
ence as indicated.
(C) Phosphorylation of TAK1 and MKK4 in RAW
264.7 cells with or without siRNA transfection as
indicated.
(D) HEK293 cells were cotransfected with HA-
GPR120 and b-arrestin2$GFP to analyze
GPR120 internalization after DHA stimulation for
the indicated times. GPR120 (red) and b-arrestin2
(green) were localized by confocal microscopy.
(E–H) (E) Coimmunoprecipitation between GPR120
and b-arrestin2 with DHA stimulation for 30 min
in RAW 264.7 cells and, (F) HEK293 cells (HA-
GPR120andb-arrestin2$GFP), respectively. Lysate
indicates 1/10 input in each experiment. Interaction
between TAB1 and b-arrestin2 (G) and interaction
between TAB1 and TAK1 (H) were detected by
coimmunoprecipitation and the scanned bar graph
quantitates the association in RAW 264.7 cells.
(I) Schematic diagram of the b-arrestin2 and
GPR120-mediated anti-inflammatory mechanism.
Red colored letters and arrows indicate the DHA-
mediated anti-inflammatory effect, and black
colored letters and arrows indicate the LPS- and
TNF-a-induced inflammatory pathway. See also
Figure S2.molecules involved in generation of GPR120 signals. As seen in
Figures 3A and 3B, LPS signaling was not affected by b-ar-
restin1, -2, or Gaq/11 knockdown. However, with b-arrestin2
knockdown, DHA-mediated anti-inflammatory signaling was ex-
tinguished, while b-arrestin1 and Gaq/11 knockdown were
without effect (Figure 3A).
Figure 3A and Figure S2 show that GPR120 stimulation inhibits
both TLR4- and TNF-amediated inflammatory responses. Since
the TNF-a and TLR signaling cascades converge downstream of
GPR120 activation, these results indicate that the site of
GPR120-induced inhibition is either at, or upstream, of JNK/
IKKb. LPS activates inflammation through the TLR4 pathway
by engaging the serine kinase IRAK, leading to phosphorylation
of transforming growth factor-b activated kinase 1 (TAK1) which
is upstream of MKK4/JNK and IKKb (Kawai and Akira, 2006,
Figure 3I). TNF-a and TLR2/3 also leads to stimulation of
TAK1, resulting in activation of IKKb and JNK (Takaesu et al.,
2003). Consequently, we determined whether DHA stimulation
of GPR120 inhibited TAK1 and MKK4. As seen in Figure 3C,
DHA treatment abrogated LPS-induced TAK1 and MKK4 phos-690 Cell 142, 687–698, September 3, 2010 ª2010 Elsevier Inc.phorylation in a GPR120 and b-arrestin2-
dependent manner. Since TLR2/3/4 and
TNF-a signaling were inhibited by
GPR120 activation, these results indicate
that DHA signaling intersects at TAK1 andinhibits all upstream input activating signals via a GPR120/b-
arrestin2 interaction (Figure 3I).
After ligand stimulation, b-arrestin2 can translocate to
a number of GPCRs where it mediates receptor internalization
and signaling (Barak et al., 1997). We transfected HEK293 cells
with b-arrestin2$GFP to visualize intracellular trafficking of b-ar-
restin2 following activation of GPR120 (Figure 3D). In the basal
state, GPR120 was localized to the plasma membrane as
assessed by immunostaining (red fluorescence, Figure 3D),
while b-arrestin2 exhibited a diffuse, largely cytoplasmic stain-
ing pattern (green, Figure 3D). Following DHA treatment for
5 min, b-arrestin2$GFP translocated from the cytosol to the
plasma membrane and can be seen colocalized with GPR120
(merged, right fields). After 30 min of DHA treatment, much of
the GPR120 is internalized, as visualized by punctate intracel-
lular staining (lower left panel), and b-arrestin2$GFP is now
colocalized with the intracellular GPR120 (lower right panel,
Figure 3D). DHA-stimulated binding of b-arrestin2 to activated
GPR120 was also detected by coimmunoprecipitation
(Figure 3E and F).
Figure 4. GPR120 Activation Enhances
GLUT4 Translocation and Glucose Uptake
(A) 3T3-L1 adipocytes were transfected with
a dually tagged HA-GLUT4-GFP construct. Total
GLUT4 expression was determined by GFP fluo-
rescence, and GLUT4 translocation to the cell
surface after 100 ng/ml insulin or 100 mM DHA
stimulation for 30 min was determined by indirect
immunofluorescence of the HA-conjugated with
Alexa 594 in fixed cells. Translocation following
insulin stimulation was expressed as a percentage
of the maximum response. The bar graph
represents the mean ± SEM data from four inde-
pendent experiments. *p < 0.05 versus vehicle
treatment. (B) Glucose uptake was measured in
WT and GPR120 KO mouse primary adipose
tissue and in (C–H) 3T3-L1 adipocytes ± siRNA
with the indicated treatment. Data are expressed
as mean ± SEM of three independent experiments
in triplicate. *p < 0.05 versus basal activity. The
indicated siRNA knockdown efficiency was vali-
dated by western blotting. See also Figure S3.LPS or TNF-a signaling activate TAK1 by causing the associ-
ation of TAK1 binding protein 1 (TAB1) with TAK1. Figure 3H
shows that LPS stimulation of RAW 264.7 cells causes TAB1/
TAK1 association. DHA treatment leads to the association of
b-arrestin2 with TAB1 (Figure 3G) and largely blocks TAK1/
TAB1 association (Figure 3H). To further examine the interaction
site of b-arrestin2 and GPR120 or TAB1, we pursued coimmuno-
precipitation with a series of b-arrestin2 truncation/deletion
mutants (Figure S2D). Full-length b-arrestin2 was able to bind
to GPR120 and TAB1 only in the presence of DHA, clearly
showing the DHA dependency of this interaction. Interestingly,
only the full-length b-arrestin2 coprecipitated with GPR120 and
TAB1, while a series of deletion/truncation b-arrestin2 mutants
did not, indicating that the interactions are dependent on the
complete tertiary structure of b-arrestin2 (Figure S2D; Luttrell
et al., 1999). Taken together, these results suggest that
GPR120 activation leads to association of b-arrestin2 with the
receptor and that this complex subsequently internalizes, where-
upon b-arrestin2 can bind to TAB1. The data further suggest that
association of b-arrestin2 with TAB1 blocks TAB1/TAK1 binding,
resulting in inhibition of TAK1 phosphorylation and activation
(Figure 3I).Cell 142, 687–698, SGPR120 Activation Enhances
Glucose Uptake in 3T3-L1
Adipocytes
Since our data show that GPR120 is
expressed in mature adipocytes and sig-
nals through Gaq/11 in these cells, we
assessed the effects of GPR120 stimula-
tion on insulin sensitivity in primary adi-
pose tissue cultures and in 3T3-L1 adipo-
cytes. Primary adipose tissue explants
and 3T3-L1 adipocytes were pretreated
for 30 min with GW9508 or DHA, followed
by measurement of basal and insulin
stimulated GLUT4 translocation (Fig-ure 4A) and 2-deoxyglucose (2-DOG) transport (Figures 4B–
4H). Ligand-stimulation of GPR120 led to an increase in glucose
transport and translocation of GLUT4 to the plasma membrane
in adipocytes, but was without effect in muscle cells (Figure S4D)
which don’t express GPR120 (Figure 1B and Figure S4C). This
stimulatory effect of DHA and GW9508 was blocked when
GPR120 or Gaq/11 was depleted by siRNA knockdown
(Figure 4D and Figure 4F). GLUT4 knockdown also blocked the
effects of DHA and GW9508, while the effects of insulin were
decreased by 90% (Figure 4E). This, along with the GLUT4
translocation data provided in Figure 4A, indicates that the
stimulatory effects of GPR120 are indeed working through
GLUT4. Further assessment of this pathway showed that DHA
had a modest effect to stimulate phosphorylation of Akt, but
that this was abrogated with GPR120 knockdown (Figure S3A).
The effects of DHA to stimulate Akt were blocked by inhibiting
PI3 kinase with LY294002 (Figure S3B). Finally, DHA did not
stimulate IRS-1 phosphorylation (Figure S3C), indicating that
its glucose transport stimulatory effects were downstream of
IRS-1. Knockdown of Gaq/11 also completely blocked the
effects of DHA to stimulate glucose transport (Figure 4F), while
b-arrestin1 or -2 knockdown was without effect (Figures 4Geptember 3, 2010 ª2010 Elsevier Inc. 691
Figure 5. In Vivo Metabolic Studies in
GPR120 KO Mice
(A) GTT in NC-fed WT and GPR120 KO mice. n = 7
per group.
(B and C) Insulin concentration was measured at
the indicated time points and (C) area-under-curve
analysisof the insulindata showsasignificantdiffer-
ence between WT and GPR120 KO mice on NC.
(D) Hyperinsulinemic/euglycemic clamp studies in
chow-fed WT and GPR120 KO mice.
(E) Clamp studies in HFD, u-3 FA supplemented
(+u3), and Rosiglitazone treated HFD mice
(+Rosi). n = 8 per group, *p < 0.05 compared to
HFD-fed WT group.
(F) Mean ± SEM plasma concentration (mole (%))
of DHA and EPA for each diet in WT and GPR120
KO mice. n = 7 per each group. *p < 0.05,
compared to NC, and **p < 0.05 compared to
HFD. Data are represented as mean ± SEM. See
also Figure S4, Figure S5, Figure S6, and Table S2.and 4H). Interestingly, Gaq/11 knockdown not only inhibited
DHA andGW9508 stimulated glucose transport, but it also atten-
uated insulin stimulatory effects, and the latter is fully consistent
with previous publication (Imamura et al., 1999) showing the role
of Gaq/11 in insulin signaling to glucose transport in adipocytes.
This scheme is shown in Figure S3D.
In Vivo Metabolic Studies in GPR120 KO Mice
Since chronic tissue inflammation can cause insulin resistance,
we hypothesized that deletion of GPR120 would enhance the
proinflammatory tone, promoting glucose intolerance and
decreased insulin sensitivity. To test this idea, GPR120
KO mice and WT littermates were evaluated on normal chow
diet (NC). Body weights were similar in both groups, and as
summarized in Figure 5, glucose tolerance tests (GTT) showed
a mild degree of impairment in GPR120 KO animals compared
to WTs (Figure 5A). More impressively, insulin secretion was
more than 2-fold greater in the KO animals, and the combination
of hyperinsulinemia and mild glucose intolerance indicates the
presence of insulin resistance (Figures 5B and 5C). This was
confirmed by performing hyperinsulinemic/euglycemic clamp
studies in the chow fed WT and KO mice (Figure 5D). These
studies revealed a 31% decrease in the glucose infusion rate692 Cell 142, 687–698, September 3, 2010 ª2010 Elsevier Inc.(GIR) required to maintain euglycemia in
the KO mice. Since 70%–80% of total
body insulin stimulated glucose disposal
is accounted for by skeletal muscle
glucose uptake (Baron et al., 1988), the
decreased insulin stimulated (IS)-glucose
disposal rate (GDR) provides direct
evidence for skeletal muscle insulin resis-
tance in the KO mice. Likewise, the
GPR120 KO mice exhibited a marked
decrease in the ability of insulin to sup-
press hepatic glucose production (HGP),
demonstrating the presence of hepatic
insulin resistance. Thus, the decreasedGIR was 50% related to muscle and 50% due to liver insulin
resistance, respectively. Since the chow diet contains exoge-
nous u-3 FAs, we conclude that blunted u-3 FA signaling in the
KO mice, accounts for the decreased insulin sensitivity.
Since u-3 FA administration can improve insulin sensitivity in
rats (Buettner et al., 2006), we reasoned that u-3 FA supplemen-
tation could alleviate HFD/obesity-induced insulin resistance in
WT mice, but would be ineffective in GPR120 KOs. Accordingly,
WTandGPR120KOmicewereplacedon60%HFD for 15weeks.
At this point, separate groups of 15 mice each, were treated for
fiveadditionalweekswith60%HFDor an isocaloricHFDdiet con-
taining27%fishoil supplementationenriched inu-3FAs. Thisdiet
provided 50 and 100 mg of DHA and EPA, respectively, per
mouse, per day. Figure 5E shows that administration of the u-3
FA diet led to improved insulin sensitivity with increased glucose
infusion rates, enhanced muscle insulin sensitivity (increased IS-
GDR), greater hepatic insulin sensitivity (increased HGP suppres-
sion), and decreased hepatic steatosis (Figures S6A and S6B).
Importantly, the u-3 FA diet was completely without effect in the
GPR120 KO mice. A separate group of WT mice were treated
with the insulin sensitizing thiazolidinedione Rosiglitazone, and
the effects ofu-3 FAs were equal to or greater (HGP suppression)
than the effects of this clinically used insulin sensitizing drug.
In addition to improving hepatic insulin sensitivity, u-3 FA
treatment had a beneficial effect on hepatic lipid metabolism,
causing decreased liver triglycerides, DAGs, along with reduced
SFA and u-6 FA content in the various lipid classes (Figures
S6A–S6C and Table S2). The u-3 FA supplementation was
entirely without effect, ormuch less effective, at reducing hepatic
lipid levels in the GPR120 KOs.
Interestingly, in the absence of u-3 FA supplementation,
GPR120 KO mice were just as susceptible to HFD-induced
insulin resistance as were the WT mice. We hypothesize that
this was because the 60% HFD is relatively deficient of exoge-
nous u-3 FAs, so that ligands for GPR120 were relatively absent
in these animals. To assess this, we performed a lipomics anal-
ysis of the various fatty acid classes in the chow andHFD-fedWT
and KO mice. As predicted, circulating concentrations of u-3
FAs were much lower on HFD compared to chow diets, and
the administration of the u-3 FA supplement to the HFD led to
a large increase in plasma u-3 FA content in both genotypes
(Figure 5F). This would account for the relative lack of effect of
GPR120 KO on HFD alone, since u-3 FA ligand stimulation is
negligible, while the KO animals displayed an insulin resistant
phenotype on chow diets when a moderate level of u-3 FAs
was provided. Importantly, the GPR120 KOmice are completely
refractory to the insulin sensitizing effects of u-3 FA administra-
tion on HFD.
To address the contribution of macrophages to the overall
in vivo phenotype, we performed bone marrow transplantation
(BMT) from GPR120 KOs into irradiated WT mice (adoptive
transfer) to generate hematopoietic cell deletion of GPR120.
The studies in the BMT WT and BMT GPR120 KO mice on
chow diet revealed a highly significant 20%–30% decrease in
GIR in the KOs, with a more dramatic impairment in the ability
of insulin to suppress hepatic glucose production (Figure S4A).
Thus, the studies in the BMT animals on the chow diet are
comparable to the results (Figure 5D) observed in WT versus
whole body GPR120 KOs on chow diet. When studied on the
HFD ±u-3 FA supplementation (Figure S4B), theu-3 FA supple-
mented BMT GPR120 KO animals exhibited a 30% decrease in
GIR compared to the u-3 FA supplemented BMTWTs. This was
explained by skeletal muscle insulin resistance (decreased IS-
GDR) and hepatic insulin resistance (decreased HGP suppres-
sion) in the GPR120 KOs compared to the WT BMT mice on
the u-3 FA supplemented HFD. These data are fully consistent
with the results in the global KOs (Figure 5E) and reinforce the
concept that the in vivo phenotype we observed can be largely
traced to hematopoietic cells/macrophages.
Omega-3 FAs Reduce Inflammatory Macrophages
in Adipose Tissue
We conducted histologic examination of adipose tissue
macrophages (ATMs) from WT and GPR120 KO mice on HFD
or the u-3 FA enriched HFD by immunostaining for the M1
macrophage marker F4/80 and the M2 macrophage marker
MGL1 (Lumeng et al., 2008) (Figure 6A). Consistent with previous
studies (Weisberg et al., 2003; Xu et al., 2003; Nguyen et al.,
2007), HFD induced a large increase in F4/80 positive ATMs,
which form crown-like structures (CLS) around adipocytes in
both WT and GPR120 KO mice. In contrast, MGL1 stainingwas minimal in both groups on HFD (Figure 6A). On the u-3 FA
diet, we observed a decrease in F4/80 staining, along with
a marked increase in MGL1 positive cells in WT mice. Impor-
tantly, no change in F4/80 or MGL1 staining was noted in the
GPR120 KO mice on the u-3 FA diet. SVFs were prepared
from adipose tissue and analyzed by flow cytometry to quanti-
tate the total number of ATMs, as well as the content of
CD11b+ and CD11c+ and negative macrophage subpopulations
(Figure 6B). HFD led to a large but comparable increase in
CD11b+ and CD11c+ ATM content in WT and GPR120 KO
mice (Figure 6B, middle panel). Treatment with the u-3 FA-en-
riched HFD caused a striking decrease in CD11b+ and CD11c+
ATMs in WT mice, but was without effect in the GPR120 KO
group (Figure 6B, right panel). Thus, the FACS analysis was fully
consistent with the histological results. Interestingly, CD11c+
ATM content was also greater in the GPR120 KOs on the chow
diet relative to WT consistent with the insulin resistance in the
KO animals.
It seemed possible that the reduction in ATM content in WT
animals on the u-3 FA diet reflected decreased chemotaxis of
macrophages. To test this hypothesis, we measured the migra-
tory capacity of IPMacs from WT and GPR120 KO mice using
an in vitro transwell chemotaxis assay. As seen in Figure 6C,
macrophages from both groups readily migrated toward condi-
tioned media (CM) harvested from 3T3-L1 adipocytes. Pretreat-
ment of macrophages with DHA for 3 hr before exposure to CM
led to an 80% inhibition of chemotactic capacity in WT macro-
phages, but had no significant effect on IPMacs obtained from
the GPR120 KO mice. Similar experiments were performed
using the specific chemokine, monocyte chemotactic protein-1
(MCP-1) as a chemoattractant, rather than CM, and these exper-
iments yielded identical results (Figure 6D). These data indicate
that u-3 FAs cause decreased macrophage chemotaxis by
acting through the GPR120 receptor, contributing to the differ-
ences in ATM content seen in Figures 6A and 6B.
Omega-3 FAs Decrease M1 Proinflammatory Gene
and Increase M2 Anti-inflammatory Gene Expression
in Adipose Tissue
As shown in Figure 7A, expression of M1 inflammatory genes
such as IL-6, TNF-a, MCP-1, IL-1b, iNOS, and CD11c was
increased by HFD compared to chow diet in both genotypes,
and was reduced in the u-3 FA treated WT mice, but not in
the GPR120 KO mice. Even on chow diet, expression of several
inflammatory genes was higher in GPR120 KOs compared to
WT, consistent with the insulin resistance observed in the
chow-fed KO mice. Expression of the M2 anti-inflammatory
genes, arginase 1, IL-10, MGL1, Ym-1, Clec7a, and MMR
was increased by u-3 FAs in WT, but not in the GPR120 KO
adipose tissue (Figure 7B). These results are consistent with
Figure 6 and demonstrate that the dietary change from HFD
to u-3 FA supplemented HFD resulted in an overall decreased
proinflammatory profile in adipose tissue from WT, but not in
GPR120 KO mice. These changes in gene expression were
predominantly manifested in the SVF, except for MCP-1 and
IL-6, which are known to be readily expressed in adipocytes
(Figure S7). Qualitatively similar results were seen in the liver
(Figures S6D and S6E).Cell 142, 687–698, September 3, 2010 ª2010 Elsevier Inc. 693
Figure 6. Omega-3 FA Enriched Diet Decreases
Inflammatory Macrophage Infiltration in Adipose
Tissue
(A) Confocal merged images from epididymal fat pads
from HFD and u-3 FA enriched HFD (HFD+u3)-fed WT
and GPR120 KO mice, costained with anti-F4/80 (green)
and anti-Caveolin1 (blue) antibodies, left 4 panels, or
anti-MGL1 (green) and anti-Caveolin1 (red) antibodies,
right 4 panels. The image is representative of similar
results from three to four independent experiments. Scale
bar represents 100 mm.
(B) Dot plot representation of CD11b versus CD11c
expression for FACS data obtained from adipose tissue
SVF of NC, HFD or HFD+u3-fed WT and GPR120 KO.
Scattergram is representative from three independent
mice from each group.
(C and D) Migratory capacity of IPMacs from WT and
GPR120 KO mice as measured using an in vitro transwell
chemotaxis assay as described under supplemental
experimental procedures. Data are expressed as mean ±
SEM of three independent experiments in triplicate. *,
p<0.05 versus CM treatment.DISCUSSION
In this report we show that GPR120 functions as an u-3 FA
receptor/sensor in proinflammatory macrophages and mature
adipocytes. By signaling through GPR120, DHA and EPA (the
major natural u-3 FA constituents of fish oil), mediate potent
anti-inflammatory effects to inhibit both TLR and TNF-a inflam-
matory signaling pathways. The mechanism of GPR120-medi-
ated anti-inflammation involves inhibition of TAK1 through a
b-arrestin2/TAB1 dependent effect. Since chronic tissue inflam-
mation is an important mechanism causing insulin resistance
(Xu et al., 2003; Shoelson et al., 2007; Schenk et al., 2008), the
anti-inflammatory actions of u-3 FAs exert potent insulin sensi-
tizing effects. The in vivo anti-inflammatory and insulin sensi-
tizing effects of u-3 FAs are dependent on expression of
GPR120, as demonstrated in studies of obese GPR120 KO
animals and WT littermates. Thus, GPR120 is highly expressed
in proinflammatory macrophages and functions as an u-3 FA
receptor, mediating the anti-inflammatory effects of this class694 Cell 142, 687–698, September 3, 2010 ª2010 Elsevier Inc.of FAs to inhibit both the TLR2/3/4 and the
TNF-a response pathways and cause systemic
insulin sensitization.
GPR120 is a Gaq/11-coupled receptor, and
since it is expressed in enteroendocrine L cells,
past interest in this receptor has focused on its
potential ability to stimulate L cell GLP-1 secre-
tion. In the current study, we show that, in addi-
tion to L cells, GPR120 is highly expressed in
proinflammatory, M1-like macrophages and
mature adipocytes, with negligible expression
in muscle, pancreatic b-cells, and hepatocytes
(Gotoh et al., 2007). In the HFD/obese mouse
model, GPR120 expression is highly induced in
ATMs as well as resident liver macrophages
(Kupffer cells). To explore the biology around
GPR120, we established an artificial reportercell assay and found that theu-3 FAs, DHA, and EPA, are ligands
for GPR120, and comparable to the effects of a non-selective
GPR120 tool compound (GW9508), the u-3 FAs exert potent
anti-inflammatory effects in macrophages. Our results also re-
vealed the molecular mechanisms underlying these anti-inflam-
matory effects. Thus, DHA stimulation of GPR120 inhibits both
the TLR2/3/4 and TNF-a proinflammatory cascade. Since acti-
vation of IKKb and JNK are common to TLR and TNF-a signaling,
this indicates that the locus of GPR120 inhibition is at or proximal
to these kinases. TAK1 activation stimulates both the IKKb/NFkB
and JNK/AP1 pathways, and the TLR and TNF-a signaling path-
ways converge at this step. Our data show that stimulation of
GPR120 specifically inhibits TAK1 phosphorylation and activa-
tion providing a common mechanism for the inhibition of both
TLR and TNF-a signaling.
Beta-arrestins can serve as important adaptor and scaffold
molecules mediating the functions of a number of different
GPCRs, as well as other receptor subtypes (Miller and Lefkowitz,
2001). The C-terminal region of GPR120 contains several
Figure 7. M1 and M2 Inflammatory Gene Expres-
sion Levels in Adipose Tissue from WT versus
GPR120 KO Mice
Relative mRNA levels for M1 proinflammatory genes (A)
and M2 anti-inflammatory genes (B) in NC, HFD, or
HFD+u3 (+u3)-fedWTandGPR120KOmice, asmeasured
by q-PCR. Data are expressed as mean ± SEM of three
independent experiments in triplicate. n=7 per group, *,
p<0.05 compared to the HFD-fed WT group. **, p<0.05
compared to the WT versus GPR120 KO on NC. See also
Figure S7. Primer sequences are shown in Table S1.putative b-arrestin2 binding motifs [(S/T)X4-5(S/T); Cen et al.,
2001], but whether b-arrestins play any role in GPR120 function
was unknown. Here we find that activation of GPR120 by DHA
stimulation leads to association of the receptor with b-arrestin2,
but not b-arrestin1, and that the anti-inflammatory effects of
GPR120 are completely b-arrestin2 dependent. Functional
immunocytochemical studies showed that DHA stimulation
leads to recruitment of b-arrestin2 to the plasma membrane
where it colocalizes with GPR120. This is followed by receptor
and b-arrestin2 internalization, where the two are now colocal-
ized in the cytoplasmic compartment. TAB1 is the activating
protein for TAK1 and our results show that following DHA-stim-
ulated internalization of the GPR120/b-arrestin2 complex,
b-arrestin2 can now associate with TAB1, as measured in coim-
munoprecipitation experiments; only full-length b-arrestin2 was
capable of interacting with GPR120 and TAB1. This apparently
blocks the association of TAB1 with TAK1, inhibiting TAK1
activation and downstream signaling to the IKKb/NFkB and
JNK/AP1 system. These results provide a mechanism for the
b-arrestin2-mediated inhibition of TLR4, TNF-a, and TLR2/3
action. Other studies in the literature are consistent with these
findings, since it has been shown that b-arrestin2 can inhibit
NFkB signaling in other systems (Gao et al., 2004; Wang et al.,
2006b). Furthermore, Lefkowitz’ group has recently published
an extensive proteomics analysis of b-arrestin2 interacting
partners, and among the 266 proteins they identified, TAB1
was represented on the list (Xiao et al., 2007).
Interestingly, the anti-inflammatory effects mediated by
GPR120 were entirely dependent on b-arrestin2, but indepen-
dent of Gaq/11, despite the fact that GPR120 can be a Gaq/Cell 142, 687–11-coupled receptor in other contexts. This
provides further evidence demonstrating the
concept that a single GPCR can independently
signal through multiple pathways. In previous
studies, we have demonstrated that Gaq/11
activation can lead to stimulation of GLUT4
translocation in adipocytes. Since GPR120
was expressed in mature adipocytes, but not
preadipocytes, we explored the potential role
of GPR120 in glucose transport control. Inter-
estingly, we found that DHA stimulation of
GPR120 in 3T3-L1 adipocytes increased
GLUT4 translocation to the cell surface with
a subsequent increase in glucose transport
into the cells. RNA interference studies showedthat the DHA effect on glucose uptake wasGPR120, GLUT4, and
Gaq/11 dependent, but independent of b-arrestin2. This effect
was about 30%–50% as great as the effect of insulin and the
actions of DHA on glucose uptake were additive to those of
a submaximally stimulating concentration of insulin. From this,
it is possible to propose that these insulinometic effects con-
tribute to the overall insulin sensitizing actions of u-3 FAs.
However, muscle glucose uptake accounts for the great majority
(70%–80%) of insulin stimulated glucose disposal. Furthermore,
GPR120 is not expressed in muscle, and DHA did not stimulated
glucose uptake in L6 myocytes (Figures S4C and S4D). In addi-
tion, acute administration of DHA had no stimulatory effects on
IS-GDR (Figure S4E). This reports the conclusion that the
in vivo stimulatory effects of DHA on GDR are related to
anti-inflammation, and that the glucose transport stimulatory
effects in adipocytes contribute little to the overall phenotype.
Since chronic, low grade tissue inflammation is an important
cause of obesity-related insulin resistance, we reasoned that
the anti-inflammatory effects of GPR120 stimulation should be
coupled to insulin sensitizing actions in vivo. This idea was
confirmed in studies of WT and GPR120 KO mice. On a chow
diet, the lean GPR120 KOmice were glucose intolerant, hyperin-
sulinemic and displayed decreased skeletal muscle and hepatic
insulin sensitivity, as measured during glucose clamp studies.
They also displayed increased ATM content, relative to WT
mice, and a 2- to 5-fold higher expression level of the M1 proin-
flammatory markers, MCP-1, iNOS, and IL-6 (Figure 7A). On
HFD, GPR120 KO and WT mice became equally obese and
insulin resistant. Importantly, u-3 FA supplementation markedly
increased insulin sensitivity in WT mice but was without effect in698, September 3, 2010 ª2010 Elsevier Inc. 695
the GPR120 KOs. Consistent with these results, u-3 FA treat-
ment led to a decrease in ATM accumulation with reduced
adipose tissue markers of inflammation in WT, but not in KO
mice. In addition to direct anti-inflammatory effects in macro-
phages, DHA treatment inhibited the ability of primary WT
macrophages to migrate toward adipocyte CM. This could be
due to DHA-induced decreased chemokine secretion or down-
regulation of chemokine receptors, or both. In addition, it is
possible that DHA, by signaling through GPR120, can mediate
heterologous desensitization of other GPCR chemokine recep-
tors. We also observed a concomitant increase in M2 markers,
such as IL-10, arginase 1, MGL1, Ym-1, Clec7a, and MMR.
This latter finding raises the possibility that u-3 FAs can redirect
ATMs from an M1 to an M2 polarization state. Taken together,
these mechanisms account for the decreased inflammatory
state. The in vivo anti-inflammatory actions of u-3 FAs are
consistent with the insulin sensitizing effects of these agents
and are fully dependent on the presence of GPR120, indicating
a causal relationship. Finally, the adoptive transfer studies
showed that hematopoietic cell GPR120 deletion results in
a comparable insulin resistant, u-3 FA non-responsive pheno-
type as seen in the global GPR120 KOs, indicating that this
phenotype can be traced back to inflammatory events in
macrophages.
We also performed a detailed in vivo lipidomic analysis of FAs
in the different lipid classes in the liver (Table S2). The results
showed that HFD leads to an increase in total TAGs, DAGs, total
SFAs, monounsaturated FAs andu-6 FAs inWTmice, while all of
these lipid changes are ameliorated withu-3 FA treatment. In the
GPR120 KO mice, all of these lipids are elevated on HFD to the
same extent as in WT mice, but, u-3 FA supplementation was
either ineffective or much less effective. These results are
consistent with the view that the reversal of steatosis/non-
alcoholic fatty liver disease (NAFLD) by u-3 FA treatment is
mediated, in large part, by GPR120 and that the GPR120 KO
mice are predisposed toward NAFLD even in the context of
u-3 FA supplementation.
Dietary DHA is rapidly esterified into chylomicrons during the
process of gastrointestinal absorption, and is also packaged
into VLDL triglycerides by the liver. DHA can also be esterified
into phospholipids and cholesterol esters associated with
circulating lipopoproteins and only a small proportion (5%) of
total plasma DHA is found in the FFA pool. Through the action
of lipoprotein lipase bound to the luminal surface of endothelial
cells, u-3 FAs are cleaved from circulating triglycerides where
they can act as ligands or be taken up by peripheral tissues
(Polozova and Salem Jr., 2007). Recent studies have also indi-
cated that metabolic products derived from u-3 FAs, such as
17S-hydroxy-DHA, resolvins, and protectins may play a role in
the long term resolution of inflammation and this might attenuate
insulin resistance in the context of obesity (Gonza´lez-Pe´riz et al.,
2009). If this proves to be correct, then this could provide an
additional mechanism for long term u-3 FA-induced anti-inflam-
matory, insulin sensitizing effects. However, in the current
studies, we found that these u-3 FA derivatives were unable to
stimulate GPR120 activation in our reporter cell assay (data not
shown), indicating that GPR120 functions as a receptor for u-3
FAs and not their biochemical products. Resolution of inflamma-696 Cell 142, 687–698, September 3, 2010 ª2010 Elsevier Inc.tion versus anti-inflammatory actions are distinct processes, and
it is certainly possible that the products derived from u-3 FA
metabolism work on the former but not the latter.
In summary, we have found that GPR120 functions as an u-3
FA receptor/sensor and mediates robust and broad anti-inflam-
matory effects, particularly inmacrophages. After ligand stimula-
tion, GPR120 couples to b-arrestin2 which is followed by
receptor endocytosis and inhibition of TAB1-mediated activation
of TAK1, providing a mechanism for inhibition of both the TLR
and TNF-a proinflammatory signaling pathways. Since chronic
tissue inflammation is linked to insulin resistance in obesity, we
used GPR120 KO mice to demonstrate that u-3 FAs cause
GPR120-mediated anti-inflammatory and insulin sensitizing
effects in vivo. Overall, these results strongly argue that anti-
inflammatory effects can ameliorate insulin resistance in obesity.
Taken together, GPR120 emerges as an important control point
in the integration of anti-inflammatory and insulin sensitizing
responses, which may prove useful in the future development
of new therapeutic approaches for the treatment of insulin resis-
tant diseases.
EXPERIMENTAL PROCEDURES
Chemicals and Reagents
GW9508 was purchased from Tocris bioscience (Ellisville, MO) and DHA was
from Cayman chemical (Ann Arbor, MI). All other chemicals were purchased
from Sigma unless mentioned otherwise.
Animal Care and Use
Male C57Bl/6 or GPR120 KO littermates were fed a normal chow (13.5% fat;
LabDiet) or high-fat diet (60% fat; Research Diet) ad libitum for 15–20 weeks
from 8 weeks of age. GPR120 KO mice and WT littermates were provided
by Taconic Inc. (Hudson, NY). After 15 weeks on HFD, WT and GPR120 KO
mice were switched to an isocaloric HFD-containing 27% menhaden fish oil
replacement (wt/wt; menhaden fish oil: 16% EPA (C20:5n3), 9%, DHA
(C22:6n3), Research Diet) (Jucker et al., 1999; Neschen et al., 2007) and fed
for 5 weeks. Mice received fresh diet every 3rd day, and food consumption
and body weight were monitored. Animals were housed in a specific path-
ogen-free facility and given free access to food and water. All procedures
were approved by the University of California, San Diego animal care and
use committee. In vivo metabolic studies were performed as described under
supplemental experimental procedures.
Data Analysis
Densitometric quantification and normalization were performed using the
ImageJ 1.42q software. The values presented are expressed as the means ±
SEM. The statistical significance of the differences between various treat-
ments was determined by one-way ANOVA with the Bonferroni correction
using GraphPad Prism 4.0 (San Diego, CA). The p < 0.05 was considered
significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, and two tables and can be found with this article online at doi:10.1016/
j.cell.2010.07.041.
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